Free Trial
NASDAQ:ULBI

Ultralife (ULBI) Stock Price, News & Analysis

Ultralife logo
$6.69 -0.39 (-5.51%)
Closing price 04:00 PM Eastern
Extended Trading
$6.70 +0.01 (+0.22%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ultralife Stock (NASDAQ:ULBI)

Advanced

Key Stats

Today's Range
$6.63
$7.00
50-Day Range
$6.51
$8.58
52-Week Range
$4.07
$9.61
Volume
51,600 shs
Average Volume
74,665 shs
Market Capitalization
$111.32 million
P/E Ratio
35.21
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Moderate Buy

Company Overview

Ultralife Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

ULBI MarketRank™: 

Ultralife scored higher than 70% of companies evaluated by MarketBeat, and ranked 263rd out of 660 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ultralife has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    Ultralife has a consensus price target of $14.00, representing about 109.3% upside from its current price of $6.69.

  • Amount of Analyst Coverage

    Ultralife has only been the subject of 1 research reports in the past 90 days.

  • Read more about Ultralife's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ultralife is 35.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.48.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ultralife is 35.21, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 495.96.

  • Price to Book Value per Share Ratio

    Ultralife has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ultralife's valuation and earnings.
  • Percentage of Shares Shorted

    1.51% of the float of Ultralife has been sold short.
  • Short Interest Ratio / Days to Cover

    Ultralife has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ultralife has recently decreased by 4.86%, indicating that investor sentiment is improving.
  • Dividend Yield

    Ultralife does not currently pay a dividend.

  • Dividend Growth

    Ultralife does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.51% of the float of Ultralife has been sold short.
  • Short Interest Ratio / Days to Cover

    Ultralife has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ultralife has recently decreased by 4.86%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ultralife this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for ULBI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    4 people have added Ultralife to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ultralife insiders have bought more of their company's stock than they have sold. Specifically, they have bought $387,049.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    40.00% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.68% of the stock of Ultralife is held by institutions.

  • Read more about Ultralife's insider trading history.
Receive ULBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ultralife and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ULBI Stock News Headlines

Head to Head Survey: Ultralife (NASDAQ:ULBI) vs. Stoneridge (NYSE:SRI)
URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.tc pixel
See More Headlines

ULBI Stock Analysis - Frequently Asked Questions

Ultralife's stock was trading at $7.45 at the beginning of 2025. Since then, ULBI stock has decreased by 10.2% and is now trading at $6.69.

Ultralife Corporation (NASDAQ:ULBI) issued its quarterly earnings data on Thursday, August, 7th. The technology company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by $0.07. The technology company had revenue of $48.56 million for the quarter, compared to analyst estimates of $51 million. Ultralife had a net margin of 1.79% and a trailing twelve-month return on equity of 2.68%.
Read the conference call transcript
.

Ultralife subsidiaries include these companies: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries India Private Limited, Ultralife Batteries (UK) LTD, Ultralife Energy Services Corporation, and Ultralife UK LTD.

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ultralife investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
8/07/2025
Today
10/07/2025
Next Earnings (Estimated)
11/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
ELEC - MISC COMPONENTS
Sub-Industry
Electrical Equipment
Current Symbol
NASDAQ:ULBI
CIK
875657
Employees
560
Year Founded
1990

Price Target and Rating

High Price Target
$14.00
Low Price Target
$14.00
Potential Upside/Downside
+107.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.19
Trailing P/E Ratio
35.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$6.31 million
Net Margins
1.79%
Pretax Margin
2.46%
Return on Equity
2.68%
Return on Assets
1.74%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
3.31
Quick Ratio
1.62

Sales & Book Value

Annual Sales
$164.46 million
Price / Sales
0.68
Cash Flow
$0.70 per share
Price / Cash Flow
9.69
Book Value
$8.07 per share
Price / Book
0.84

Miscellaneous

Outstanding Shares
16,640,000
Free Float
9,986,000
Market Cap
$112.50 million
Optionable
No Data
Beta
1.06

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ULBI) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners